David Traynor
Internal Medicine · Huntsville, ALNPI 1942689765
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 249 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,213 and has fallen 86.7% since, to $162 in 2022.
Across 249 payments — averaging $12.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$727
- Takeda Pharmaceuticals U.S.A., Inc.$497
- Pfizer$305
- Boehringer Ingelheim$265
- Lilly USA, LLC$244
- AstraZeneca$202
- plus $865 from 16 others
What the payments were for
- Food & beverage$3,098100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 86 | $727 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $497 |
| Pfizer | 21 | $305 |
| Boehringer Ingelheim | 20 | $265 |
| Lilly USA, LLC | 17 | $244 |
| AstraZeneca | 17 | $202 |
| AbbVie(2 entities) | 16 | $192 |
| Amgen | 8 | $142 |
| Amarin Pharma, Inc. | 6 | $109 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $87 |
| GSK | 4 | $55 |
| Merck | 4 | $48 |
| Abbott | 3 | $46 |
| Genentech USA, Inc. | 3 | $45 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Daiichi Sankyo Inc. | 2 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $14 |
| Bausch Health US, LLC | 1 | $12 |
| Novartis | 1 | $12 |
| Adlon Therapeutics L.p. | 1 | $11 |
How this compares
$3,104 in reported general payments places this provider in the 80th percentile of 1,533 internal medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 18 | $300 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Huntsville
- Joseph HastieHuntsville$44K
- Vytautas PukisHuntsville$16K
- Tanja DudenbostelHuntsville$14K
- Ryan WeldonBirmingham$458K
- Thomas McKelveyMobile$365K
- Mary HonkanenMobile$302K
- Robert LewisBirmingham$187K
- Rosalind BowlesGadsden$168K
- Sonja PettusJasper$117K
- Bobby WrightsMobile$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.